Form 4 for CVS CVS Health
Accepted 2023-05-05 00:00:00 ET · period of report 2023-05-03 · accession 0001127602-23-014615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-05 | 2023-05-03 | CVS | Lynch Karen S | Pres, CEO, Dir | P - Purchase | $69.75 | +14.0K | 431.4K | +3% | +$976.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (By Trust) | 2023-05-03 | P | A | 14,000 | $69.75 | 431,392 | D | — | — |